| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
|
Ann Intern Med
|
1980
|
1.95
|
|
2
|
Therapeutic response in phase I trials of antineoplastic agents.
|
Cancer Treat Rep
|
1986
|
1.91
|
|
3
|
Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.
|
JAMA
|
1988
|
1.51
|
|
4
|
5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
|
Cancer
|
1979
|
1.17
|
|
5
|
Phase-II trial of tamoxifen in advanced breat cancer.
|
Cancer Chemother Pharmacol
|
1979
|
0.95
|
|
6
|
Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent.
|
Invest New Drugs
|
1986
|
0.93
|
|
7
|
Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea.
|
Cancer Res
|
1978
|
0.92
|
|
8
|
Clinical drug development: an analysis of phase II trials, 1970-1985.
|
Cancer Treat Rep
|
1987
|
0.92
|
|
9
|
Phase I clinical trial of spirogermanium.
|
Cancer Treat Rep
|
1981
|
0.91
|
|
10
|
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
|
Cancer Treat Rep
|
1976
|
0.89
|
|
11
|
A comparison of mitoxantrone and doxorubicin in breast cancer.
|
J Clin Oncol
|
1986
|
0.84
|
|
12
|
Results of NCI-sponsored phase I trials with carboplatin.
|
Cancer Treat Rev
|
1985
|
0.84
|
|
13
|
Mitomycin C: experience in the United States, with emphasis on gastric cancer.
|
Cancer Chemother Pharmacol
|
1978
|
0.84
|
|
14
|
Overview of the preclinical development of an antiretroviral drug, 2',3'-dideoxyinosine.
|
Rev Infect Dis
|
1990
|
0.83
|
|
15
|
Gallium nitrate: the second metal with clinical activity.
|
Cancer Treat Rep
|
1986
|
0.80
|
|
16
|
Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.
|
Cancer Treat Rep
|
1986
|
0.79
|
|
17
|
AIDS drug discovery and development.
|
J Acquir Immune Defic Syndr
|
1989
|
0.78
|
|
18
|
Phase I studies on chlorozotocin.
|
Clin Pharmacol Ther
|
1978
|
0.77
|
|
19
|
Investigational trials of anticancer drugs: establishing safeguards for experimentation.
|
Public Health Rep
|
1984
|
0.75
|
|
20
|
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
|
Cancer Treat Rep
|
1986
|
0.75
|
|
21
|
A phase II study of chlorozotocin in advanced large bowel carcinoma. A cooperative study between two institutions.
|
Am J Clin Oncol
|
1984
|
0.75
|
|
22
|
Phase II study of chlorozotocin in leukemia and other hematologic malignancies.
|
Cancer Treat Rep
|
1982
|
0.75
|
|
23
|
Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
|
Recent Results Cancer Res
|
1980
|
0.75
|
|
24
|
Phase II study of chlorozotocin in non-small cell carcinoma of the lung.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
25
|
Hexamethylmelamine: a critical review of an active drug.
|
Cancer Treat Rev
|
1986
|
0.75
|
|
26
|
Mitomycin C: experience in the United States, with emphasis on gastric cancer.
|
Recent Results Cancer Res
|
1978
|
0.75
|